XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Balance at Dec. 31, 2020 $ 1,152,783 $ 1,168 $ 589,241 $ 562,374
Balance, shares at Dec. 31, 2020   116,829,000    
Merger consideration 3,658,362 $ 896 3,657,466  
Merger consideration, shares   89,586,000    
Vesting of restricted stock units   $ 6 (6)  
Vesting of restricted stock units, shares   648,000    
Stock-based compensation expense 10,402   10,402  
Exercise of stock options 235 $ 1 234  
Exercise of stock options, shares   27,000    
Shares withheld for restricted stock units vested (10,417) $ (2) (10,415)  
Shares withheld for restricted stock units vested, shares   (232,000)    
Net income 172,580     172,580
Balance at Mar. 31, 2021 4,983,945 $ 2,069 4,246,922 734,954
Balance, shares at Mar. 31, 2021   206,858,000    
Balance at Dec. 31, 2021 $ 4,802,481 $ 1,798 4,260,670 540,013
Balance, shares at Dec. 31, 2021 179,820,000 179,820,000    
Vesting of restricted stock units   $ 11 (11)  
Vesting of restricted stock units, shares   1,018,000    
Stock-based compensation expense $ 8,840   8,840  
Repurchase of common stock [1] (285,951) $ (36)   (285,915)
Exercise of stock options 421   421  
Exercise of stock options, shares   42,000    
Shares withheld for restricted stock units vested (29,384) $ (4) (29,380)  
Shares withheld for restricted stock units vested, shares   (401,000)    
Net income 639,640     639,640
Balance at Mar. 31, 2022 $ 5,136,047 $ 1,769 $ 4,240,540 $ 893,738
Balance, shares at Mar. 31, 2022 176,886,000 176,886,000    
Repurchase of common stock, shares (3.6) (3,593,000) [1]    
[1] During the three months ended March 31, 2022, we repurchased and retired approximately 3.6 million shares of our common stock at an average price of $79.58 per share for $286.0 million, net of fees, pursuant to the repurchase programs authorized by our board of directors in November 2021 and February 2022.